Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchalzheimersamyloid-betabioinformaticsbiomarkers

Bioinformatics study screens amyloid-beta therapeutics and Alzheimer's biomarkers

BioMed Research International authors used computational methods to identify candidate Abeta-targeted agents and diagnostic markers.

PR
By Priya Raman · Science Reporter
Dec 31 19:00 ETSource: BioMed research international

The wire

  1. 01Li and colleagues reported bioinformatics-driven discovery of amyloid-beta-targeted therapeutics and diagnostic biomarkers for Alzheimer's disease.
  2. 02Computational screening can prioritize peptide and small-molecule candidates before lab testing.
  3. 03Named candidates and validation status are not provided in the excerpt.

From the source

Bioinformatics-Driven Discovery of Aβ-Targeted Therapeutics and Diagnostic Biomarkers for Alzheimer's Disease

BioMed research international · 2026 · Li X, Liu X, Song X et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42752992/